Business
COEGIN: Strong R&D progress and partnerships, but future funding remains a key uncertainty
COEGIN: Strong R&D progress and partnerships, but future funding remains a key uncertainty
About this update from Coegin Pharma Ab
Coegin Pharma advanced its peptide-based hair growth and skin pigmentation projects, improved its financial position, and secured key partnerships, but faces material uncertainty regarding future financing beyond Q4 2025. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.